Xuhao Huang

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Mesenchymal Stem Cells

Gold Nanoparticles

Top Venues

Current issues in molecular biology

This page only lists publications with an associated author ORCID identifier.

Publications

Erina Hilmayanti, Xuhao Huang, Supriatno Salam, null Nurlelasari, Unang Supratman, Kazuya Kabayama, Koichi Fukase
In Vitro Anti-Inflammatory Study of Limonoids Isolated from Chisocheton Plants. Current issues in molecular biology 46 (1) (2024)
Erina Hilmayanti, Xuhao Huang, Supriatno Salam, null Nurlelasari, Unang Supratman, Kazuya Kabayama, Koichi Fukase
In Vitro Anti-Inflammatory Study of Limonoids Isolated from Chisocheton Plants. Current issues in molecular biology 46 (1) (2024)
Xuhao Huang, Kazuko Kaneda-Nakashima, Yuichiro Kadonaga, Kazuya Kabayama, Atsushi Shimoyama, Kazuhiro Ooe, Hiroki Kato, Atsushi Toyoshima, Atsushi Shinohara, Hiromitsu Haba, Yang Wang, Koichi Fukase
Astatine-211-Labeled Gold Nanoparticles for Targeted Alpha-Particle Therapy via Intravenous Injection. Pharmaceutics 14 (12) (2022)
Xuhao Huang, Kazuko Kaneda-Nakashima, Yuichiro Kadonaga, Kazuya Kabayama, Atsushi Shimoyama, Kazuhiro Ooe, Hiroki Kato, Atsushi Toyoshima, Atsushi Shinohara, Hiromitsu Haba, Yang Wang, Koichi Fukase
Astatine-211-Labeled Gold Nanoparticles for Targeted Alpha-Particle Therapy via Intravenous Injection. Pharmaceutics 14 (12) (2022)
Xuhao Huang, Kazuko Kaneda-Nakashima, Yuichiro Kadonaga, Kazuya Kabayama, Atsushi Shimoyama, Kazuhiro Ooe, Hiroki Kato, Atsushi Toyoshima, Atsushi Shinohara, Hiromitsu Haba, Yang Wang, Koichi Fukase
Astatine-211-Labeled Gold Nanoparticles for Targeted Alpha-Particle Therapy via Intravenous Injection. Pharmaceutics 14 (12) (2022)
Xuhao Huang, Kazuko Kaneda-Nakashima, Yuichiro Kadonaga, Kazuya Kabayama, Atsushi Shimoyama, Kazuhiro Ooe, Hiroki Kato, Atsushi Toyoshima, Atsushi Shinohara, Hiromitsu Haba, Yang Wang, Koichi Fukase
Astatine-211-Labeled Gold Nanoparticles for Targeted Alpha-Particle Therapy via Intravenous Injection. Pharmaceutics 14 (12) (2022)